Drugs / Leuprorelin Acetate Depot
last change Feb 2010 re-read 2 minutes ago

Leuprorelin Acetate Depot

Developed for
endometriosis
Investigated by
AbbVie

Trials 1 · a red edge is where a trial was stopped

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00797225 Nov 2008 → Feb 2010 endometriosis AbbVie Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Leuprorelin Acetate Depot ClinicalTrials.gov intervention name — accepted as the source's own label NCT00797225
Route Intramuscular “administered as an intramuscular injection” NCT00797225